Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement. [electronic resource]
- The Journal of clinical endocrinology and metabolism 02 2018
- 768-777 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1945-7197
10.1210/jc.2017-01542 doi
Adolescent Adult Child Child, Preschool Craniopharyngioma--complications Female Hormone Replacement Therapy Human Growth Hormone--therapeutic use Humans Hypopituitarism--drug therapy Male Middle Aged Morbidity Mortality Pituitary Neoplasms--complications Retrospective Studies Risk Risk Factors Young Adult